SARMS UK - Research Grade

SARMs (Selective Androgen Receptor Modulators) are synthetic compounds designed to bind selectively to androgen receptors in the body.

Unlike anabolic steroids, which activate receptors throughout many tissues, SARMs target specific areas — primarily muscle and bone — while avoiding others like the prostate or liver. Ostarine is prime example of this class.

This selective action allows researchers to explore anabolic effects (such as increased muscle mass or bone density) with reduced systemic side effects. SARMs are commonly studied in contexts like muscle wasting, osteoporosis, and hormonal regulation, but they remain investigational and are not approved for human consumption.

Moving in 2026 - New information available

Where to start : SARMs glossary

Need to check the law? SARMs law update for 2026

Check out our Buying Guide 

SARMS - Compared

Compound Receptor Selectivity Typical Research Range* Half-Life Key Research Observations Distinctive Features
Ostarine (MK-2866) High AR affinity (muscle/bone) 1–3 mg/day ~24 hours Frequently analysed for lean mass and musculoskeletal studies Most studied SARM in published literature
Ligandrol (LGD-4033) Potent AR binding 0.1–1 mg/day ~24–36 hours Phase I/II trials on strength and mass Higher AR affinity vs MK-2866
RAD-140 (Testolone) Very high AR selectivity 0.1–1 mg/day ~16–24 hours Explored for neuroprotection and bone effects Strongest AR agonist in SARM category
Andarine (S-4) Moderate AR selectivity 25–50 mg/day ~3–6 hours Examined for muscle/bone pathways Short half-life, often divided in studies
ACP-105 Potent AR activation 1–10 mg/day ~4–6 hours Strong signalling effects in rodent studies Often compared to RAD-140
S23 Very strong AR selectivity 0.5–5 mg/day ~11–12 hours Studied for male contraception models Extremely potent; narrow research applications
YK-11 Partial AR agonist (myostatin modulation) 1–10 mg/day ~6 hours* Mostly in vitro/in vivo data Hybrid steroidal-SARM mechanism
MK-677 (Ibutamoren)† GH secretagogue (not a SARM) 5–25 mg/day ~6 hours GH/IGF-1 axis signalling and sleep studies Oral GH secretagogue
SR9009† REV-ERB agonist (not a SARM) 20–30 mg/day ~2–4 hours Circadian and metabolic research Mechanistically unrelated to AR pathways

*Research ranges reference published experimental literature — not guidance for human consumption.

† Not a SARM; included due to common comparison in research discussions.

Testing procedures

Third-Party Testing
Every Batch, No Exceptions

Every compound we supply comes with a batch-specific Certificate of Analysis (COA) from an accredited third-party lab. We use validated methods like HPLC and LC-MS/MS to confirm:

  • Compound identity Purity (≥98%)
  • Absence of contaminants or adulterants

You’ll always know exactly what you’re working with — no assumptions, no guesswork.

Professional Grade
Packaging and Fulfilment

Your order is handled like a research shipment should be:

  • Sealed, tamper-evident containers
  • Discreet, trackable delivery (Royal Mail, DPD)

Same-day dispatch on weekdays for most orders

We’ve designed every step of the process to protect compound integrity and researcher confidence.

UK Legislation Compliance

Safety handling compliance

Our SARMs are shipped with physical copies of the Material Safety Datasheet, and are labelled with the specific hazard classification for each compound.

 

Research supply only

We only supply our compounds to those involved in the research and development industry. Checks are undertaken to ensure correct possession and usage of our compounds

Next day UK SARMS delivery
& effective customs clearance

Royal Mail 24

We aim to ship stocked items within 24 hours of ordering, Monday to Friday

Customs Clearance

We have extensive experience in working with international customs to ensure the correct assessment and hassle-free import for your order

How We Maintain REACH Compliance for SARMs

Stock threshold control

We supply in small batches for laboratory use, well below the 1-tonne annual threshold that triggers mandatory REACH registration. This means formal registration is not currently required — but other obligations still apply.

Safe Handling, Packaging & Labelling

We ensure all research compounds are:

  • Labeled with appropriate hazard warnings (GHS/CLP-compliant)
  • Supplied with SDS (Safety Data Sheets) where applicable
  • Packaged in a way that prevents leakage, degradation, or contamination
SARMs research in 2025, a book showcasing the study

Our latest research-based resource

While stocks last! ⚡ Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for